- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02901574
Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment
Cerebellar Transcranial Direct Current Stimulation to Augment Chronic Aphasia Treatment
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators will study the effect of right cerebellar transcranial direct current stimulation (tDCS) stimulation during language therapy for naming in individuals with chronic aphasia (>6 months post stroke). Naming difficulties are a persistent and common symptom in aphasia after left-hemisphere (LH) stroke. Although the interventions to improve naming can have benefits, a massive number of treatment sessions is usually required to show gains, particularly in individuals with chronic, large LH stroke. tDCS is a promising adjunct to traditional language therapy. tDCS is a safe, non-invasive, non-painful electrical stimulation of the brain which modulates cortical excitability by application of weak electrical currents in the form of direct current brain polarization. It is usually administered via saline-soaked surface sponge electrodes attached to the scalp and connected to a direct current stimulator with low intensities. Prior investigators have mainly focused on the role of LH in language recovery, wherein the electrode is placed in the left frontal or temporal region. However, in individuals with large lesions involving key language areas like the frontal and temporal cortex, it may be difficult to find viable tissue to stimulate in the LH. This study uses a novel electrode placement for chronic stroke patients with aphasia with large LH lesions. Targeting the intact right cerebellum allows for the possibility of identifying a single target that can be used across groups of people with aphasia with varying lesion sites and size in the LH. Evidence from functional neuroimaging and clinical studies indicate that the right cerebellum is important for both language and cognitive functions.
The investigators will utilize a randomized, double-blind, sham controlled, within-subject crossover trial design. A random subset (half) of participants will be assigned to the "anode" group (Group Anode) and other half will be assigned to the 'cathode' group (Group Cathode). Participants will take part in 2 intervention periods of 15 computerized naming training sessions (3-5 sessions per week), with either tDCS + naming therapy or sham+ naming therapy, separated by 2 months. Detailed language evaluation will take place before, immediately after, 2 weeks and 2 months post-intervention for each condition. The investigators will test the hypothesis that anodal tDCS or cathodal tDCS over the cerebellum and computerized naming therapy is associated with greater gains in accuracy in naming pictures, compared to sham combined with the same computerized naming therapy.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants must have sustained a left hemisphere stroke.
- Participants must be fluent speakers of English by self-report.
- Participants must be capable of giving informed consent or indicating another to provide informed consent.
- Participants must be age 18 or older.
- Participants must be premorbidly right handed.
- Participants must be at least 6 months post stroke.
- Participants must have an aphasia diagnosis as confirmed by the Boston Diagnostic Aphasia Examination (BDAE) Short Form.
- Participants must achieve at least 65% accuracy on screening task (comparable to treatment task) on 1 of 3 attempts
Exclusion Criteria:
- Participants with lesion involving the right cerebellum
- Previous neurological or psychiatric disease.
- Seizures during the previous 12 months.
- Uncorrected visual loss or hearing loss by self-report.
- Use of medications that lower the seizure threshold (e.g., methylphenidate, amphetamine salts).
- Use of N-methyl-D-aspartate receptor (NMDA) antagonists (e.g., memantine).
- > 80% (140 out of 175) correct responses on the Philadelphia Naming Test at baseline.
- History of brain surgery or any metal in the head.
- Scalp sensitivity (per participant report).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: tDCS plus computerized naming therapy
Anodal or cathodal tDCS, 2 milliamps (mA) plus computerized naming treatment for 15 sessions (20 minutes per each 45 minute treatment session) over the course of 3-5 weeks.The electrical current will be administered to the right cerebellum.
The stimulation will be delivered at an intensity of 2 mA for a maximum of 20 minutes.
Language therapy will be a computer delivered naming +picture matching task.
|
2 mA or Anodal or Cathodal tDCS stimulation is induced between 5cm X5 cm saline soaked sponges where one sponge (anode in group anode or cathode in group cathode) is placed on the right cerebellum.
The stimulation will be delivered at an intensity of 2 mA in a ramp-like fashion for a maximum of 20 minutes.
Computer delivered naming treatment requires matching (heard and seen being produced by the speaker) with pictures depicting common objects.
It is run on a laptop computer with headphones and 2 large response buttons.
During treatment, a picture appears on the laptop screen for 2 seconds.
Then, a video of the speaker's face below the nose is presented on the screen saying a word that either matches or does not match the picture.
The participant is instructed to press a green response button if the word matches the picture and press the red button if the word does not match the picture.
|
Sham Comparator: Sham plus computerized naming therapy
Sham tDCS plus computerized naming treatment for 15 sessions (20 minutes per each 45 minute treatment session) over the course of 3-5 weeks.
Current will be administered in the in a ramp like fashion for 15-30 seconds but then the current is gradually decreased and drop to 0 mA.
Language therapy will be a computer delivered naming +picture matching task.
|
Computer delivered naming treatment requires matching (heard and seen being produced by the speaker) with pictures depicting common objects.
It is run on a laptop computer with headphones and 2 large response buttons.
During treatment, a picture appears on the laptop screen for 2 seconds.
Then, a video of the speaker's face below the nose is presented on the screen saying a word that either matches or does not match the picture.
The participant is instructed to press a green response button if the word matches the picture and press the red button if the word does not match the picture.
2 mA of Anodal tDCS or Cathodal tDCS is induced between two 5cm X 5cn saline soaked sponges where one sponge (anode in group Anode and cathode in group Cathode) is placed on the right cerebellum.
Ramping up of the current to 2 mA occurs over 15-30 seconds to allow participants to habituate to the tingling sensation.
Then, the current will be ramped back down to 0 mA in the sham condition.
Termination of the stimulation after the ramping up process is generally undetectable, and the brief duration of stimulation yields no functional effects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Accuracy of Naming Untrained Pictures (Philadelphia Naming Test:PNT) Pre-treatment to Post-treatment
Time Frame: Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment.
|
To determine whether tDCS coupled with computerized naming therapy will improve naming performance of participants with post stroke aphasia more effectively than naming therapy alone (i.e., the sham condition).The PNT is a 175-item picture naming test where a person earns one point per each correct answer.
Scores range from 0-175 with higher scores associated with better performance.
|
Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Accuracy of Naming Untrained Pictures (Philadelphia Naming Test:PNT)Pre-treatment to 2 Weeks Post-treatment.
Time Frame: Pre-treatment and at 2 weeks Post-treatment
|
To determine whether tDCS coupled with computerized naming therapy will improve naming performance of participants with post stroke aphasia more effectively than naming therapy alone (i.e., the sham condition).The PNT is a 175-item picture naming test where a person earns one point per each correct answer.
Scores range from 0-175 with higher scores associated with better performance.
|
Pre-treatment and at 2 weeks Post-treatment
|
Change in Accuracy of Naming Untrained Pictures (Philadelphia Naming Test:PNT) Pre-treatment to 2 Months Post-treatment.
Time Frame: Pre-treatment and at 2 months Post-treatment
|
To determine whether tDCS coupled with computerized naming therapy will improve naming performance of participants with post stroke aphasia more effectively than naming therapy alone (i.e., the sham condition).The PNT is a 175-item picture naming test where a person earns one point per each correct answer.
Scores range from 0-175 with higher scores associated with better performance.
|
Pre-treatment and at 2 months Post-treatment
|
Change in Functional Communication Skills on the ASHA-FACS Communication Independence Scale Pre-treatment to Post-treatment
Time Frame: Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment.
|
The American Speech-Language-Hearing Association Functional Assessment of Communication Skills for Adults (ASHA FACS) will be administered at Pre- treatment and Post-treatment to evaluate changes in functional communication skills.The ASHA-FACS Communication Independence scale measures functional communication performance along a continuum of independence, in terms of levels of assistance and/or prompting needed in-order to communicate. The 7-point scale ranges from 1) "does not perform the behavior" to 7) "does perform the behavior". Higher scores means better functional communication independence. of communication independence Scale (CI) |
Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment.
|
Change in Functional Communication Skills on the ASHA-FACS Communication Independence Scale Pre-treatment to 2 Weeks Post-treatment
Time Frame: Pre-treatment and at 2 weeks Post-treatment
|
The American Speech-Language-Hearing Association Functional Assessment of Communication Skills for Adults (ASHA FACS) will be administered pre- treatment and 2 weeks post treatment to evaluate changes in functional communication skills.The ASHA-FACS Communication Independence scale measures functional communication performance along a continuum of independence, in terms of levels of assistance and/or prompting needed in-order to communicate.
The 7-point scale ranges from 1) "does not perform the behavior" to 7) "does perform the behavior".
Higher scores means better functional communication independence.
|
Pre-treatment and at 2 weeks Post-treatment
|
Change in Functional Communication Skills on the ASHA-FACS Communication Independence Scale Pre-treatment to 2 Months Post-treatment
Time Frame: Pre-treatment and at 2 months Post-treatment
|
The American Speech-Language-Hearing Association Functional Assessment of Communication Skills for Adults (ASHA FACS) will be administered pre- treatment and 2 months post treatment to evaluate changes in functional communication skills.The ASHA-FACS Communication Independence scale measures functional communication performance along a continuum of independence, in terms of levels of assistance and/or prompting needed in-order to communicate.
The 7-point scale ranges from 1) "does not perform the behavior" to 7) "does perform the behavior".
Higher scores means better functional communication independence.
|
Pre-treatment and at 2 months Post-treatment
|
Change in Functional Communication Skills on the ASHA-FACS Qualitative Dimensions of Communication Scale Pre-treatment to Post-treatment
Time Frame: Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment.
|
The American Speech-Language-Hearing Association Functional Assessment of Communication Skills for Adults (ASHA FACS) will be administered pre-treatment and post-treatment to evaluate changes in functional communication skills. The ASHA-FACS Qualitative Dimensions of Communication Scale is rated on a 5-point scale reflecting adequacy, appropriateness, and promptness of communication and communication sharing. The 5-point scale ranges from 1) "communication is never relevant/without delay" to 5) "communication is always relevant/ without delay". Higher scores means better functional communication outcome. |
Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment.
|
Change in Functional Communication Skills on the ASHA-FACS Qualitative Dimensions of Communication Scale Pre-Treatment to 2 Week Post-Treatment
Time Frame: Pre-treatment and at 2 weeks Post-treatment
|
The American Speech-Language-Hearing Association Functional Assessment of Communication Skills for Adults (ASHA FACS) will be administered pre-treatment and 2 weeks post-treatment to evaluate changes in functional communication skills.
The ASHA-FACS Qualitative Dimensions of Communication Scale is rated on a 5-point scale reflecting adequacy, appropriateness, and promptness of communication and communication sharing.
The 5-point scale ranges from 1) "communication is never relevant/without delay" to 5) "communication is always relevant/ without delay".
Higher scores means better functional communication outcome.
|
Pre-treatment and at 2 weeks Post-treatment
|
Change in Functional Communication Skills on the ASHA-FACS Qualitative Dimensions of Communication Scale Pre-treatment to 2 Months Post-treatment
Time Frame: Pre-treatment and at 2 months Post-treatment
|
The American Speech-Language-Hearing Association Functional Assessment of Communication Skills for Adults (ASHA FACS) will be administered pre-treatment and 2 months post-treatment to evaluate changes in functional communication skills.
The ASHA-FACS Qualitative Dimensions of Communication Scale is rated on a 5-point scale reflecting adequacy, appropriateness, and promptness of communication and communication sharing.
The 5-point scale ranges from 1) "communication is never relevant/without delay" to 5) "communication is always relevant/ without delay".
Higher scores means better functional communication outcome.
|
Pre-treatment and at 2 months Post-treatment
|
Change in Discourse Ability Pre-treatment to Post-treatment.
Time Frame: Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment
|
The investigators will record the administration of the Cinderella Story Discourse Analysis task to compare changes in core production of words from pre-treatment to post-treatment. The investigators will transcribe the story told by participants at pre and post-treatment and count the total number of words produced on a Core Lexicon checklist. There are 95 words on the Core Lexicon checklist which conveys the story of Cinderella. A person earns one point for each word produced from the checklist when telling the story. Production scores range from 0-95 with higher scores associated with better performance on this discourse task. |
Before and after 15 sessions (3-5 sessions per week; up to 5 weeks) of treatment
|
Change in Discourse Ability Pre- Treatment to 2 Weeks Post-treatment.
Time Frame: Pre-treatment and at 2 weeks Post-treatment
|
The investigators will record the administration of the Cinderella Story Discourse Analysis task to compare changes in core production of words from pre- treatment to 2 weeks post treatment. The investigators will transcribe the story told by participants at pre and post-treatment and count the total number of words produced on a Core Lexicon checklist. There are 95 words on the Core Lexicon checklist which conveys the story of Cinderella. A person earns one point for each word produced from the checklist when telling the story. Production scores range from 0-95 with higher scores associated with better performance on this discourse task. |
Pre-treatment and at 2 weeks Post-treatment
|
Change in Discourse Ability Pre-treatment to 2 Months Post-treatment.
Time Frame: Pre-treatment and at 2 months Post-treatment
|
The investigators will record the administration of the Cinderella Story Discourse Analysis task to compare changes in core production of words from Pre-treatment to 2 months Post-treatment. The investigators will transcribe the story told by participants at pre and 2 months post-treatment and count the total number of words produced on a Core Lexicon checklist. There are 95 words on the Core Lexicon checklist which conveys the story of Cinderella. A person earns one point for each word produced from the checklist when telling the story. Production scores range from 0-95 with higher scores associated with better performance on this discourse task. |
Pre-treatment and at 2 months Post-treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rajani Sebastian, PhD, CCC-SLP, Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00100024
- R00DC015554 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Anodal or Cathodal tDCS
-
New York UniversityRecruiting
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedMotor Activity | Motor NeuroplasticityUnited States
-
Charite University, Berlin, GermanyCompletedMigraine With Aura | CADASIL | Cerebral Microangiopathy | ICA StenosisGermany
-
Universidade Federal de PernambucoCompleted
-
Universidade Federal de PernambucoUnknown
-
University Hospital MuensterUnknown
-
The University of Texas at DallasActive, not recruiting
-
Universidade Federal de PernambucoCompletedStroke | Transcranial Direct Current StimulationBrazil
-
Sunnybrook Health Sciences CentreCompleted
-
University Hospital TuebingenActive, not recruitingObesity | Insulin Resistance | Diabetes Type 2Germany